Domain and Website Information:
oncogenomics.es
Domain name - oncogenomics.es
Site title - Oncogenomics
Go to website - Oncogenomics
Site GEO location
Location Country - Spain
Provider - acens Technologies, S.L.
Site Logo
IP address:
Domain name servers:
ns2.srv-acens.com ns1.srv-acens.com
All records:
☆ oncogenomics.es. 3600 IN SOA ns1.srv-acens.com. info.oncogenomics.es. 2025837673 14400 7200 2419200 3600
☆ oncogenomics.es. 3600 IN NS ns2.srv-acens.com.
☆ oncogenomics.es. 3600 IN NS ns1.srv-acens.com.
☆ oncogenomics.es. 300 IN A 79.139.120.56
☆ oncogenomics.es. 300 IN MX 30 alt3.aspmx.l.google.com.
☆ oncogenomics.es. 300 IN MX 20 alt1.aspmx.l.google.com.
☆ oncogenomics.es. 300 IN MX 30 alt4.aspmx.l.google.com.
☆ oncogenomics.es. 300 IN MX 10 aspmx.l.google.com.
☆ oncogenomics.es. 300 IN MX 20 alt2.aspmx.l.google.com.
☆ oncogenomics.es. 300 IN TXT "v=spf1 include:_spf.google.com include:spf.dominioabsoluto.net ~all"
☆ oncogenomics.es. 300 IN TXT "google-site-verification=5djMrWUH5eDXzBpKREYz06IckS_LDQirgmPE3Sd1Hqc"
☆ oncogenomics.es. 300 IN TXT "4y40n0r8lyg0z1367y8yfbwcft33mzzk"
Brief facts about oncogenomics:
Oncogenomics is a sub-field of genomics that characterizes cancer-associated genes. It focuses on genomic, epigenomic and transcript alterations in cancer. Cancer is a genetic disease caused by accumulation of DNA mutations and epigenetic alterations leading to unrestrained cell proliferation and neoplasm formation. The goal of oncogenomics is to identify new oncogenes or tumor suppressor genes that may provide new insights into cancer diagnosis, predicting clinical outcome of cancers and new targets for cancer therapies. The success of targeted cancer therapies such as Gleevec, Herceptin and Avastin raised the hope for oncogenomics to elucidate new targets for cancer treatment. Besides understanding the underlying genetic mechanisms that initiate or drive cancer progression, oncogenomics targets personalized cancer treatment. Cancer develops due to DNA mutations and epigenetic alterations that accumulate randomly.
International Cancer Genome Consortium - The International Cancer Genome Consortium is a voluntary scientific organization that provides a forum for collaboration among the world's leading cancer and genomic researchers.
Personalized onco-genomics - Personalized onco-genomics is the field of oncology and genomics that is focused on using whole genome analysis to make personalized clinical treatment decisions. The program was devised at British Columbia's BC Cancer Agency and is currently being led by Marco Marra and Janessa Laskin.
The Cancer Genome Atlas - The Cancer Genome Atlas is a project to catalogue the genetic mutations responsible for cancer using genome sequencing and bioinformatics.
© DMS 2011-